Medtronic shows mixed results with strong Cardiovascular growth and weaker Neuroscience/MedSurg. Click here to read an ...

The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.

Intuitive Surgical is currently the leader in robotic surgery, thanks to a lineup of products that includes the Ion system, ...

Truist raised the firm’s price target on Medtronic (MDT) to $96 from $92 and keeps a Hold rating on the shares. The company’s in-line Q1 organic ...

Citi analyst Joanne Wuensch raised the firm’s price target on Medtronic (MDT) to $101 from $99 and keeps a Buy rating on the shares. The firm ...

A clutch of post-earnings price target increases by analysts helped raise Medtronic 's (NYSE: MDT) stock at a healthy rate on ...

The S&P 500 declined 0.2% on Wednesday, Aug. 20, 2025, as tech stocks slid and minutes from the latest Federal Reserve ...

Raymond James analyst Jayson Bedford reiterated a Hold rating on Medtronic on August 18. The company’s shares closed yesterday at $89.90. Elevate Your Investing Strategy: Take a ...

Medtronic has appointed John Groetelaars and Bill Jellison to its board as independent directors, effective immediately, and formed two board committees.

Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and ...

The global Neonatal Care Equipment Market, valued at US$2.0 billion in 2024, stood at US$2.06 billion in 2025 and is projected to advance at ...

Jellison currently serves as a Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and ...